Home › Funds › Commodore Capital LP › KYMR

Commodore Capital LP position in KYMR

KYMERA THERAPEUTICS INC · Health Care

Commodore Capital LP reported holding 250,000 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$28.7M, representing 1.71% of its reported portfolio and ranking #18 among its reported holdings. Commodore Capital LP has disclosed KYMR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)250.00K sh
Reported value held$28.67M
Portfolio Weight1.71%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's KYMR position evolved

Commodore Capital LP first disclosed a stake in KYMR in Q2 2025 at 750,000 shares (US$32.7M). The position peaked in Q1 2026 at 750,000 shares, worth US$62.5M. Across 5 filings, Commodore Capital LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 250,000 shares valued at US$28.7M — a reduction of -500,000 shares quarter over quarter.. Notable position changes include a 67% trim in Q2 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 750.00K $32.73M New
Q3 2025 750.00K $42.45M Hold
Q4 2025 750.00K $58.36M Hold
Q1 2026 750.00K $62.47M Hold
Q2 2026 250.00K $28.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 57 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$857.1M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has Commodore Capital LP held KYMR?

Commodore Capital LP has disclosed KYMR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Commodore Capital LP's current position in KYMR?

As of Q2 2026, Commodore Capital LP holds 250.00K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $28.67M, representing 1.71% of its reported portfolio and ranking #18.

Has Commodore Capital LP been buying or selling KYMR?

In the latest 13F filing (Q2 2026), Commodore Capital LP reduced its position in KYMR. The position peaked in Q1 2026 at 750.00K shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.